NASDAQ : AHG
Akso Health Group — Financial statements
Healthcare · Medical Distribution · China
Last price 1.26 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.08B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Akso Health Group (AHG) reported revenue of 13.83M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 13.83M | 13.83M | 14.78M | 2.41M | 13.18M | 6.00M |
| Revenue | 13.83M | 13.83M | 14.78M | 2.41M | 13.18M | 6.00M |
| Cost of Revenue | 13.84M | 13.84M | 15.06M | 2.29M | 11.91M | 5.39M |
| Gross Profit | -11.31K | -11.31K | -281.53K | 122.13K | 1.27M | 605.13K |
| Selling, General & Admin | 3.99M | 3.99M | 3.64M | 8.76M | 15.54M | 2.67M |
| Operating Expenses | 3.99M | 3.99M | 3.64M | 8.76M | 15.54M | 3.06M |
| Operating Income | -4.00M | -4.00M | -3.92M | -8.64M | -14.27M | -2.46M |
| Interest Expense | -804.14K | |||||
| Currency Exchange Gain (Loss) | 272.00 | 272.00 | -26.00 | -591.99K | 1.14M | -748.50K |
| Other Non Operating Income (Expenses) | -4.38K | -4.38K | 34.10K | 138.24K | 57.36K | 684.00 |
| EBT Excluding Unusual Items | -4.00M | -4.00M | -3.89M | -9.09M | -13.07M | -4.01M |
| Impairment of Goodwill | -11.07M | -11.07M | -41.37M | |||
| Asset Writedown | -5.63M | -5.63M | -121.01M | |||
| Pretax Income | -20.70M | -20.70M | -166.27M | -9.09M | -13.07M | -4.01M |
| Income Tax Expense | -1.99M | -1.99M | -30.80M | 24.99K | 17.55K | 92.82K |
| Earnings From Continuing Operations | -18.72M | -18.72M | -135.47M | -9.12M | -13.08M | -4.10M |
| Earnings From Discontinued Operations | -399.80K | 11.84M | -12.75M | |||
| Net Income to Company | -18.72M | -18.72M | -135.47M | -9.52M | -1.25M | -16.85M |
| Minority Interest in Earnings | 44.57K | 44.57K | 491.76K | 57.79K | -112.50K | -1.33K |
| Net Income | -18.67M | -18.67M | -134.98M | -9.46M | -1.36M | -16.85M |
| Net Income to Common | -18.67M | -18.67M | -134.98M | -9.46M | -1.36M | -16.85M |
| Shares Outstanding (Basic) | 722.71M | 722.71M | 285.10M | 47.17M | 22.87M | 19.87M |
| Shares Outstanding (Diluted) | 722.71M | 722.71M | 285.10M | 47.17M | 22.87M | 19.87M |
| EPS (Basic) | -0.03 | -0.03 | -0.47 | -0.20 | -0.06 | -0.85 |
| EPS (Diluted) | -0.03 | -0.03 | -0.48 | -0.22 | -0.08 | -0.85 |
| Free Cash Flow | -12.79M | -12.79M | 1.02M | 1.35M | -3.25M | -8.63M |
| Free Cash Flow Per Share | -0.02 | -0.02 | 0.00 | 0.03 | -0.14 | -0.43 |
| Gross Margin | -0.08% | -0.08% | -1.91% | 5.06% | 9.63% | 10.09% |
| Operating Margin | -28.92% | -28.92% | -26.55% | -357.78% | -108.23% | -40.94% |
| Profit Margin | -134.99% | -134.99% | -913.38% | -391.77% | -10.32% | -280.85% |
| Free Cash Flow Margin | -92.49% | -92.49% | 6.92% | 55.97% | -24.68% | -143.81% |
| EBITDA | -1.63M | -1.63M | -1.77M | -14.25M | -2.44M | |
| EBITDA Margin | -11.77% | -11.77% | -12.00% | -108.09% | -40.63% | |
| D&A For EBITDA | 2.37M | 2.37M | 2.15M | 18.39K | 18.39K | |
| EBIT | -4.00M | -4.00M | -3.92M | -8.64M | -14.27M | -2.46M |
| EBIT Margin | -28.92% | -28.92% | -26.55% | -108.23% | -40.94% | |
| Revenue as Reported | 13.83M | 13.83M | 14.78M | 2.41M | 13.18M | 6.00M |
| Advertising Expenses | 168.42K | 6.66K |
Balance sheet
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 170.57K | 170.57K | 176.23M | 85.17M | 7.92M | 18.43M |
| Cash & Short-Term Investments | 170.57K | 170.57K | 176.23M | 85.17M | 7.92M | 18.43M |
| Accounts Receivable | 1.28M | 1.28M | 954.20K | 7.70M | ||
| Receivables | 1.28M | 1.28M | 12.90M | 9.23M | 20.00M | |
| Inventory | 200.13K | 200.13K | 190.24K | 191.20K | 1.69M | 7.80M |
| Other Current Assets | 187.89M | 187.89M | 6.81M | 56.65M | 1.62M | 16.58M |
| Total Current Assets | 189.55M | 189.55M | 196.12M | 142.02M | 20.46M | 62.81M |
| Property, Plant & Equipment | 28.91K | 28.91K | 114.54K | |||
| Goodwill | 10.83M | |||||
| Other Intangible Assets | 58.32K | 58.32K | 7.88M | |||
| Total Assets | 189.63M | 189.63M | 214.95M | 142.02M | 20.46M | 62.81M |
| Accrued Expenses | 1.84M | 1.84M | 1.46M | 1.09M | 938.88K | 225.88K |
| Short-Term Debt | 2.35M | 2.35M | 2.00M | 2.00M | 9.69M | 37.20M |
| Current Portion of Leases | 22.57K | 22.57K | 40.06K | |||
| Current Income Taxes Payable | 92.82K | 92.82K | 92.82K | 92.82K | 95.89K | 92.82K |
| Other Current Liabilities | 4.41M | 4.41M | 10.22M | 415.02K | 899.86K | 13.00M |
| Total Current Liabilities | 8.71M | 8.71M | 13.81M | 3.59M | 11.62M | 50.52M |
| Long-Term Leases | 2.56K | 2.56K | 41.68K | |||
| Long-Term Deferred Tax Liabilities | 1.95M | |||||
| Total Liabilities | 8.71M | 8.71M | 15.80M | 3.59M | 11.62M | 50.52M |
| Common Stock | 257.13K | 257.13K | 165.68K | 43.83K | 6.98K | 6.98K |
| Additional Paid-In Capital | 405.53M | 405.53M | 405.62M | 210.32M | 71.02M | 71.02M |
| Retained Earnings | -217.58M | -217.58M | -198.90M | -63.93M | -54.47M | -53.11M |
| Treasury Stock | -3.99M | -3.99M | -3.99M | -3.99M | -3.99M | -3.99M |
| Comprehensive Income & Other | -3.28M | -3.28M | -3.77M | -4.09M | -3.85M | -1.65M |
| Total Common Equity | 180.93M | 180.93M | 199.12M | 138.37M | 8.73M | 12.28M |
| Minority Interest | -12.23K | -12.23K | 31.99K | 56.81K | 114.21K | 1.98K |
| Shareholders' Equity | 180.92M | 180.92M | 199.15M | 138.42M | 8.84M | 12.29M |
| Total Liabilities & Equity | 189.63M | 189.63M | 214.95M | 142.02M | 20.46M | 62.81M |
| Total Debt | 2.38M | 2.38M | 2.08M | 2.00M | 9.69M | 37.20M |
| Net Cash (Debt) | -2.21M | -2.21M | 174.15M | 83.17M | -1.76M | -18.77M |
| Net Cash Per Share | -0.00 | -0.00 | 0.61 | 1.76 | -0.08 | -0.94 |
| Filing Date Shares Outstanding | 856.70M | 856.70M | 551.86M | 145.72M | 22.87M | 22.87M |
| Total Common Shares Outstanding | 856.70M | 856.70M | 551.86M | 145.72M | 22.87M | 22.87M |
| Working Capital | 180.84M | 180.84M | 182.31M | 138.42M | 8.84M | 12.29M |
| Book Value Per Share | 0.21 | 0.21 | 0.36 | 0.95 | 0.38 | 0.54 |
| Tangible Book Value | 180.88M | 180.88M | 180.41M | 138.37M | 8.73M | 12.28M |
| Tangible Book Value Per Share | 0.21 | 0.21 | 0.33 | 0.95 | 0.38 | 0.54 |
| Machinery | 20.37K | 20.37K | 17.76K |
Cash flow statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -18.67M | -18.67M | -134.98M | -9.46M | -1.36M | -16.85M |
| Depreciation & Amortization | 2.37M | 2.37M | 2.15M | |||
| Asset Writedown & Restructuring Costs | 16.70M | 16.70M | 162.48M | |||
| Stock-Based Compensation | 391.62K | |||||
| Provision & Write-off of Bad Debts | 108.62K | 108.62K | -100.00K | 7.37M | 8.27M | |
| Other Operating Activities | -1.95M | -1.95M | -31.39M | 737.92K | -11.72M | 12.75M |
| Change in Accounts Receivable | -435.48K | -435.48K | -859.54K | 327.19K | -8.10M | |
| Change in Inventory | 1.50M | 6.11M | -7.80M | |||
| Change in Accounts Payable | 312.99K | 312.99K | 417.18K | 166.04K | 712.88K | 148.54K |
| Change in Unearned Revenue | -5.81M | -5.81M | 9.86M | 220.64K | 194.38K | |
| Change in Income Taxes | 59.42K | 59.42K | -40.55K | -21.91K | 3.19K | 92.82K |
| Change in Other Net Operating Assets | -5.48M | -5.48M | -6.36M | -130.77K | -95.15K | -16.53K |
| Operating Cash Flow | -12.79M | -12.79M | 1.18M | 1.35M | -3.25M | -8.63M |
| Capital Expenditures | -1.64K | -1.64K | -154.46K | |||
| Cash Acquisitions | -93.75M | -56.25M | ||||
| Sale (Purchase) of Intangibles | -175.66M | -175.66M | ||||
| Other Investing Activities | 36.14K | |||||
| Investing Cash Flow | -163.46M | -163.46M | -105.91M | -54.72M | 18.47M | -19.96M |
| Short-Term Debt Issued | 350.00K | 350.00K | 9.09M | |||
| Total Debt Issued | 350.00K | 350.00K | 9.09M | |||
| Short-Term Debt Repaid | -7.69M | -27.51M | ||||
| Long-Term Debt Repaid | -10.00M | |||||
| Total Debt Repaid | -7.69M | -27.51M | -10.00M | |||
| Net Debt Issued (Repaid) | 350.00K | 350.00K | -7.69M | -27.51M | -913.20K | |
| Issuance of Common Stock | 195.88M | 139.34M | 10.02M | |||
| Other Financing Activities | 25.68M | |||||
| Financing Cash Flow | 350.00K | 350.00K | 195.88M | 131.65M | -27.51M | 34.78M |
| Foreign Exchange Rate Adjustments | -153.48K | -153.48K | -1.12M | -1.27M | -436.51K | 607.72K |
| Net Cash Flow | -176.06M | -176.06M | 90.03M | 77.01M | -12.73M | 6.80M |
| Free Cash Flow | -12.79M | -12.79M | 1.02M | 1.35M | -3.25M | -8.63M |
| Free Cash Flow Margin | -92.49% | -92.49% | 6.92% | 55.97% | -24.68% | -143.81% |
| Free Cash Flow Per Share | -0.02 | -0.02 | 0.00 | 0.03 | -0.14 | -0.43 |
| Levered Free Cash Flow | -350.71M | -350.71M | 46.67M | -50.05M | 11.54M | -19.15M |
| Unlevered Free Cash Flow | -350.71M | -350.71M | 46.67M | -50.05M | 11.54M | -18.65M |
| Cash Interest Paid | 111.56K | 336.59K | 676.89K | |||
| Cash Income Tax Paid | 1.79K | 1.79K | 2.98K | 24.99K | 17.55K | 92.82K |
| Change in Working Capital | -11.35M | -11.35M | 3.02M | 2.06M | -1.17M | -7.57M |
Ratios
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.08B | 1.95B | 425.20M | 169.70M | 8.12M | 38.64M |
| Enterprise Value | 1.08B | 1.94B | 340.67M | 170.58M | 7.83M | 35.19M |
| Last Close Price | 1.26 | 2.28 | 1.18 | 1.16 | 0.35 | 1.69 |
| Forward PE | 5.08 | 5.08 | 5.08 | 5.08 | 5.08 | |
| PS Ratio | 78.04 | 141.22 | 28.77 | 70.29 | 0.62 | 6.44 |
| PB Ratio | 5.97 | 10.80 | 2.13 | 1.23 | 0.92 | 3.15 |
| P/TBV Ratio | 5.97 | 10.80 | 2.36 | 1.23 | 0.93 | 3.15 |
| P/FCF Ratio | 415.76 | 125.59 | ||||
| P/OCF Ratio | 361.20 | 125.59 | ||||
| PEG Ratio | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | |
| EV/Sales Ratio | 78.20 | 140.56 | 23.05 | 70.65 | 0.59 | 5.86 |
| EV/FCF Ratio | 333.10 | 126.24 | ||||
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 1.10 | 3.03 |
| Debt / FCF Ratio | 2.04 | 1.48 | ||||
| Net Debt / Equity Ratio | 0.01 | 0.01 | -0.87 | -0.60 | 0.20 | 1.53 |
| Net Debt / EBITDA Ratio | -1.35 | -1.35 | 98.21 | -0.12 | -7.70 | |
| Net Debt / FCF Ratio | -0.17 | -0.17 | -170.28 | -61.55 | -0.54 | -2.17 |
| Asset Turnover | 0.07 | 0.07 | 0.08 | 0.03 | 0.32 | 0.13 |
| Inventory Turnover | 70.92 | 70.92 | 78.96 | 2.44 | 2.51 | |
| Quick Ratio | 0.17 | 0.17 | 12.83 | 23.70 | 1.34 | 0.36 |
| Current Ratio | 21.77 | 21.77 | 14.20 | 39.52 | 1.76 | 1.24 |
| Return on Equity (ROE) | -9.85% | -9.85% | -80.26% | -12.38% | -123.87% | -27.75% |
| Return on Assets (ROA) | -1.24% | -1.24% | -1.37% | -6.64% | -21.42% | -3.25% |
| Return on Invested Capital (ROIC) | -2.18% | -3.84% | -9.78% | -26.24% | -68.50% | -10.64% |
| Return on Capital Employed (ROCE) | -2.20% | -2.20% | -2.00% | -6.20% | -161.40% | -20.00% |
| Earnings Yield | -2.38% | -0.96% | -31.75% | -5.57% | -16.75% | -43.61% |
| FCF Yield | -1.19% | -0.66% | 0.24% | 0.80% | -40.08% | -22.33% |
| Buyback Yield / Dilution | -153.50% | -153.50% | -504.37% | -106.30% | -15.07% | -22.06% |
| Total Shareholder Return | -153.50% | -153.50% | -504.37% | -106.30% | -15.07% | -22.06% |